Article
Discovery of a Highly Selective and H435R-Sensitive Thyroid Hormone Receptor β Agonist.
Journal of medicinal chemistry - 26 May 2022
Li Qiu, Yao Benqiang, Zhao Shiting, Lu Zhou, Zhang Yan, Xiang Qiuping, Wu Xishan, Yu Haonan, Zhang Cheng, Li Junhua, Zhuang Xiaoxi, Wu Donghai, Li Yong, Xu Yong
Abstract excerpt
The design and development of agonists selectively targeting thyroid hormone receptor β (TRβ) and TRβ mutants remain challenging tasks. In this study, we first adopted the strategy of breaking the "His-Phe switch" to solve two problems, simultaneously. A structure-based design approach was successfully utilized to obtain compound 16g, which is a potent TRβ agonist (EC50: 21.0 nM, 85.0% of the maximum efficacy of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
